TABLE 1.
Clinical characteristics of four patients with P. fluorescens bacteremia
| Patient no. | Age (yr)/ sexf | Underlying disease | Associated condition | Isolation data
|
Treatment (duration [days]) | |||
|---|---|---|---|---|---|---|---|---|
| Locationb | Isolate designa- tionc | Date (day/mo/yr) | Initial identification | |||||
| 1 | 50/F | Breast liposarcoma, liver and thyroid metastasis | Port-A-Cath inserted | OW | A | 7/3/97 | NFGNBd | Mefoxitin (5); ceftazidime plus amikacin (14) |
| 2 | 47/M | Non-Hodgkin’s lymphoma | Port-A-Cath inserted, leukopeniaa | CR | B1 | 17/3/97 | P. fluorescens or P. putida | Noe |
| CR | B2 | 17/3/97 | P. fluorescens or P. putida | |||||
| 3 | 26/M | Hodgkin’s disease | Port-A-Cath inserted, leukopenia | CR | C1 | 19/3/97 | B. pickettii | No |
| CR | C2 | 19/3/97 | P. fluorescens or P. putida | |||||
| 4 | 66/M | Gastric lymphoma | Port-A-Cath inserted, leukopenia | CR | D1 | 17/3/97 | B. pickettii | No |
| CR | D2 | 24/3/97 | P. fluorescens or P. putida | Ceftazidime (2); ciprofloxacin (7) | ||||
| CR | D3 | 24/3/97 | B. pickettii | Catheter removal | ||||
a
Defined as a leukocyte count <4.0 × 109/liter.
b
OW, oncology ward; CR, chemotherapy room.
c
Isolate D3 was recovered from a blood specimen collected from a Port-A-Cath, and others (A to D2) were recovered from blood specimens drawn from peripheral veins.
d
NFGNB, nonfermentative gram-negative bacilli.
e
No, no treatment.
f
M, male; F, female.